| Financial Year |
March 31 2023 |
| Monetary Funds |
494,718,416.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
296,280,172.37 |
| Advances to Suppliers |
31,553,246.64 |
| Other Receivables |
404,452,723.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
153,685,867.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
33,343,335.79 |
| Total Current Assets |
1,424,846,638.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
683,853,418.89 |
| Under-construction Projects |
43,107,664.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
252,650,231.58 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
48,203,908.86 |
| Deferred Income Tax Assets |
129,368,160.10 |
| Other Non-Current Assets |
12,549,607.42 |
| Sub-Total of Non-Current Assets |
1,214,855,299.22 |
| Total Assets |
2,639,701,937.27 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
18,582,177.88 |
| Accounts Payable |
265,048,250.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,330,266.45 |
| Taxes Payable |
81,265,083.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
201,083,643.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
21,803,908.55 |
| Other Current Liabilities |
1,995,640.48 |
| Sub-Total of Current Liabilities |
618,042,443.12 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
17,484,774.47 |
| Deferred Income Tax Liabilities |
25,489,869.22 |
| Other Non-Current Liabilities |
4,141.60 |
| Sub-Total of Non-Current Liabilities |
129,014,047.87 |
| Total Liabilities |
747,056,490.99 |
| Paid-In Capital(Or Share Stock) |
2,268,393,386.00 |
| Capital Surplus |
6,678,646,725.50 |
| Surplus Reserve |
19,341,126.64 |
| LESS:Treasury Stock |
122,829,532.00 |
| Undistributed Profits |
-6,895,786,659.87 |
| Minority Stockholder's Interest |
-55,054,183.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,947,699,629.87 |
| Owner's Equity（Stockholder's Equity） |
1,892,645,446.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,639,701,937.27 |
